Belle, a telehealth company offering compounded tirzepatide treatment through licensed U.S. medical providers, announced that it has been included in RetailHub's 2026 guide ranking the best places to get tirzepatide without insurance.

RetailHub is an online publisher that produces comparison guides and reviews across consumer product and service categories. Its 2026 tirzepatide guide evaluates five cash-pay providers based on factors including monthly cost and pricing structure, clinical support, pharmacy credentials, medication format options, and customer reputation. For readers covering the full cost of treatment themselves, those criteria lay out the practical yardsticks for comparing telehealth programs side by side.

In the ranking, Belle received a score of 4.9 out of 5.0. According to the guide, Belle offers flat monthly pricing that does not increase as patients move through dose titration — a structure that keeps the monthly cost predictable over the course of a plan. Plans start at $175 per month on a starter package, $199 per month on a six-month term, and $249 per month on a month-to-month basis, with a $99-per-month microdose option also available. The guide additionally referenced weekly group nutrition sessions included with Belle's plans and noted that the company's patient base has grown past 30,000.

Belle states that every patient consultation is conducted by a licensed U.S. medical provider. Before any prescription is issued, the provider reviews the patient's health history, goals, and eligibility to determine whether treatment is clinically appropriate. The company is LegitScript-certified, meaning its telehealth practices have been independently verified for compliance with applicable laws and regulations, and it partners exclusively with accredited U.S. compounding pharmacies. In a cash-pay model, where no insurer is vetting providers on a patient's behalf, independently verifiable credentials of this kind give consumers a concrete reference point when weighing telehealth options.

"Being included in RetailHub's comparison of tirzepatide providers reflects the work our clinical and pharmacy partners put into building a compliant, transparent program," the Belle team said in the announcement. "Our priority continues to be making sure every patient is evaluated by a licensed provider before starting treatment."

The full ranking and methodology are available at RetailHub's website, so readers can see exactly how the five providers were measured on each criterion.

About Belle

Belle is a U.S. telehealth company that provides compounded tirzepatide treatment to cash-pay patients. Patient consultations are conducted by licensed U.S. medical providers, who review each patient's health history and eligibility before prescribing. Belle is LegitScript-certified and works exclusively with accredited U.S. compounding pharmacies for medication fulfillment.

About RetailHub

RetailHub is an online publisher that produces buyer's guides and reviews comparing brands and providers across a range of consumer product and service categories.

The information contained in this announcement is based on materials provided by the company and third-party sources referenced herein. This content is for informational purposes only and does not constitute medical, health, or professional advice. Individual results may vary.